Vaccines, Blood & Biologics
2012 Biological New Drug Application (NDA) and Abbreviated New Drug Application (ANDA) Approvals
This list reflects information regarding the applications as of the approval date. It is not updated with regard to applicant or application status changes.
|Tradename||Indication for Use||NDA Number||Applicant||Approval Date|
|Anticoagulant Citrate Dextrose Solution, USP (ACD-A)||For the extracorporeal processing of blood with Autologous PRP systems in production of platelet rich plasma (PRP) for in vitro use.||BA110057||Arteriocyte Medical Systems, Inc.|
45 South Street, Suite 3
Hopkinton, MA 01748